Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

1.1K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.1K
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

131
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
131
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

1.6K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.6K
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

615
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
615
Adrenergic Agonists: Therapeutic Uses01:30

Adrenergic Agonists: Therapeutic Uses

1.5K
Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
1.5K
Angina IV: Management01:26

Angina IV: Management

164
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
164

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Real-world insights into young-onset gastroesophageal adenocarcinoma: an all-Ireland population-based cancer registry analysis.

ESMO gastrointestinal oncology·2026
Same author

Risk factors, management and consequences of severe menopausal vasomotor symptoms.

Nature reviews. Endocrinology·2026
Same author

Modern Management of the Menopause: Are We Measuring What Matters?

BJOG : an international journal of obstetrics and gynaecology·2026
Same author

Sexual Function, Activity and Distress 24 Months After Surgical Menopause: What Happens After Menopause (WHAM)-A Prospective Controlled Study.

BJOG : an international journal of obstetrics and gynaecology·2026
Same author

Women's and Health Care Professionals' Experiences of Discontinuing Hormone Replacement Therapy (HRT): A Systematic Review.

BJOG : an international journal of obstetrics and gynaecology·2025
Same author

Maternal sepsis: a 5-year single center review.

Irish medical journal·2025

Related Experiment Video

Updated: Dec 14, 2025

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
06:18

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause

Published on: August 13, 2019

12.7K

Managing vasomotor symptoms effectively without hormones.

C A McCormick1, A Brennan1, M Hickey1

  • 1Department of Obstetrics and Gynaecology, University of Melbourne and the Royal Women's Hospital, Parkville, VIC, Australia.

Climacteric : the Journal of the International Menopause Society
|July 23, 2020
PubMed
Summary
This summary is machine-generated.

Hot flushes and night sweats significantly impact women during menopause. This review explores effective non-hormonal treatments for vasomotor symptoms when menopausal hormone therapy is not preferred.

Keywords:
Menopausebreast cancerhot flushmenopausal hormone therapynon-hormonalnon-pharmacologicalvasomotor

More Related Videos

Herbs-Partitioned Moxibustion on the Navel in a Rat Model of Primary Dysmenorrhea with Cold Coagulation and Blood Stasis
05:36

Herbs-Partitioned Moxibustion on the Navel in a Rat Model of Primary Dysmenorrhea with Cold Coagulation and Blood Stasis

Published on: October 4, 2024

969
Author Spotlight: Exploring the Effects of Transauricular Vagus Nerve Stimulation
04:59

Author Spotlight: Exploring the Effects of Transauricular Vagus Nerve Stimulation

Published on: January 19, 2024

3.3K

Related Experiment Videos

Last Updated: Dec 14, 2025

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
06:18

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause

Published on: August 13, 2019

12.7K
Herbs-Partitioned Moxibustion on the Navel in a Rat Model of Primary Dysmenorrhea with Cold Coagulation and Blood Stasis
05:36

Herbs-Partitioned Moxibustion on the Navel in a Rat Model of Primary Dysmenorrhea with Cold Coagulation and Blood Stasis

Published on: October 4, 2024

969
Author Spotlight: Exploring the Effects of Transauricular Vagus Nerve Stimulation
04:59

Author Spotlight: Exploring the Effects of Transauricular Vagus Nerve Stimulation

Published on: January 19, 2024

3.3K

Area of Science:

  • Reproductive Medicine
  • Women's Health
  • Menopause Management

Background:

  • Vasomotor symptoms (hot flushes, night sweats) affect ~80% of women during menopause.
  • These symptoms significantly impair quality of life, productivity, and relationships.
  • Vasomotor symptoms are a primary reason for seeking medical care during the menopausal transition.

Purpose of the Study:

  • To review evidence for non-hormonal treatments for vasomotor symptoms.
  • To provide a clinical algorithm for managing symptomatic women.
  • To address the needs of women who do not opt for menopausal hormone therapy.

Main Methods:

  • Comprehensive literature review of pharmacological and non-pharmacological interventions.
  • Analysis of clinical trial data and treatment guidelines.
  • Development of a decision-making algorithm for clinicians.

Main Results:

  • Non-hormonal pharmacological options offer effective relief for vasomotor symptoms.
  • Non-pharmacological approaches, such as lifestyle modifications and behavioral therapies, can also be beneficial.
  • The clinical algorithm guides selection based on symptom severity and patient preference.

Conclusions:

  • Effective non-hormonal treatments are available for vasomotor symptoms.
  • A structured approach aids in personalized management of menopausal symptoms.
  • Increased access to non-hormonal options can improve quality of life for many women.